Radiosensitization of p53-Deficient Lung Cancer Cells by Pre-treatment with Cytostatic Compounds

Anticancer Research, 04/11/2012

The proposed therapeutic strategy allows protection of p53 wild–type cells and selectively increases radiosensitivity of p53–deficient cancer cells.

Print Article Summary Cat 2 CME Report